03:12
Short: Webinar Highlighting Oramed's Positive Phase 2 NASH Data
52:08
Webinar Highlighting Oramed's Positive Phase 2 NASH Data
01:01:28
The Journey of Oral Insulin (Part 1) The Oramed Story ft Nadav Kidron
01:05:09
The Journey of Oral Insulin (Part 2) The Oramed Story ft. Prof. Avram Hershko and Dr. Miriam Kidron
59:14
The Need for Oral Insulin in Type 2 Diabetes; Webinar Hosted by: Oramed Pharmaceuticals ($ORMP)
01:11
Short: The Need for Oral Insulin in Type 2 Diabetes; Webinar Hosted by Oramed Pharmaceuticals
02:49
Oramed Pharmaceuticals ($ORMP) Oral Delivery Platform
00:48
Nadav Kidron, CEO of Oramed: We Can Better The Lives of Hundreds of Millions
01:22
Oramed CEO Nadav Kirdon's Message to Shareholders Jan 2022
01:14
100 years after the discovery of insulin - Now a new revolution underway with oral insulin
03:00
Oravax Oral Covid Vaccine Animation
04:15
Nadav Kidron speaks to Joe Donlon on the Donlon Report
00:55
Oravax Medical - Imagine Oral Vaccines
04:42
Oramed CEO Nadav Kidron on i24NEWS Dec 13 2020
00:58
Nadav Kidron's Message to Oramed Shareholders 2020 1Q
01:14
Oral Insulin Could Potentially Cause a Revolution in how We Treat Diabetics - Nadav Kidron
01:03
Oramed Pharamaceuticals is Developing Oral Insulin
01:15
CEO Nadav Kidron Discusses Oramed's Oral Insulin Platform Technology
03:05
Oramed Pharamceuticals Corporate Video - Chinese Subtitles
00:49
Oramed Pharmaceuticals Corporate Video Short - Chinese Subtitles
01:07
Nadav Kidron: Why Oramed Pharmaceuticals is a Game Changer for Diabetics
00:48
Nadav Kidron, CEO of Oramed: We Can Better The Lives of Hundreds of Millions
03:05
Oramed Pharmaceuticals: Innovating Oral Delivery Systems For Injectable Medications
18:35
Nadav Kidron of Oramed Pharmaceuticals is a keynote speaker at Sy Syms Event
02:16
i24news: Israeli drugmaker Oramed Pharmaceuticals Successfully Tests Insulin Pill
03:27
ILTV: Israeli Company Oramed Pharmaceuticals Develops Groundbreaking Diabetes Pill
03:45
Oramed advisor Prof. Avram Hershko, Noble prize winner for Chemistry
03:19
Israeli Presidential Conference
04:46
Nadav Kidron--Oramed CEO on Fox Business
02:13
Oramed Medical Animation
01:49
Oramed Technology
01:34
Oramed Rings the Nasdaq Closing Bell
01:53
Oramed' Oral Insulin Animation
X
About
Oramed Pharmaceuticals (NASDAQ: ORMP) has developed an innovative technology to transform injectable treatments into oral therapies.
Oramed’s flagship product, an oral insulin capsule, has the potential to better the lives of millions of diabetics around the world – allowing, amongst other things, type 2 patients to begin insulin therapy earlier without fear of needles.
Oramed’s oral insulin is currently in advanced clinical trials under the US FDA for both type 1 and type 2 diabetes.
In addition to oral insulin, the company’s proprietary POD™ technology can be used to orally administer a number of protein-based therapies, which are available only via injection.
Tags